British Journal of Anaesthesia, 2003, Vol. 91, No. 3 445-446
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia
Correspondence |
HIT/HITT and alternative anticoagulation: current concepts
1 Nottingham, UK 2 Manchester, UK 3 Aberdeen, UK
| The first 10% of the full text of this article appears below. |
EditorWe read with interest the Editorial by Pravinkumar and Webster,1 but were disappointed that the authors did not expand on heparin-induced thrombocytopenia (HIT)-rate-reduction by empiric use of low molecular weight heparin (LMWH). Many of the traditional uses of unfractionated heparin (UFH) have been superceded by the introduction of LMWH, including treatment of deep venous thrombosis, pulmonary embolism, and acute coronary syndromes. One of the under-explored therapeutic indications of LMWH is as the anticoagulant of choice for critically ill patients requiring continuous veno-venous haemofiltration (CVVH). We recently reported our experience in 52 consecutive patients to the Intensive Care Society of Great Britain.2
Traditionally, it is believed that LMWH has a lower HIT rate than
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. A. Saad, E. Pravinkumar, and N. R. Webster HIT/HITT and alternative anticoagulation: current concepts Br. J. Anaesth., October 1, 2003; 91(4): 606 - 607. [Full Text] [PDF] |
||||
